Form 4: UnitedHealth Group Director Stephen J. Hemsley Reports Changes in Beneficial Ownership

Director Stephen J. Hemsley reports acquisition of deferred stock units and adjustments to beneficial ownership of UnitedHealth Group stock.

Summary

• On July 1, 2024, Stephen J. Hemsley, a director of UnitedHealth Group, reported changes in his beneficial ownership of the company's stock.
• Hemsley acquired 289 shares of common stock as deferred stock units, a form of quarterly compensation for his service as a director.
• These deferred stock units are immediately vested but must be retained until Hemsley completes his service on the Board.
• The transaction was reported on July 2, 2024, by Faraz A. Choudhry, Attorney-in-Fact for Stephen J. Hemsley.
• Hemsley's direct holdings of common stock following the transaction amount to 810,856.942 shares.
• Hemsley also has indirect ownership through various GRATs and a 401(k).

Sentiment

Score: 7

Explanation: The document reflects standard insider trading activity related to director compensation, which is neither overtly positive nor negative. It provides transparency, which is generally viewed favorably.

Positives

• The acquisition of deferred stock units aligns the director's interests with the long-term performance of the company.
• The director's continued service on the board is incentivized by the vesting conditions of the deferred stock units.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, ensuring fair market practices.

Stakeholder Impact

• Shareholders are informed about changes in the beneficial ownership of a key company director.
• The filing ensures transparency and compliance with SEC regulations.

Key Dates